<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01098448</url>
  </required_header>
  <id_info>
    <org_study_id>NIDCR-012861</org_study_id>
    <nct_id>NCT01098448</nct_id>
  </id_info>
  <brief_title>Control of Periodontal Infections</brief_title>
  <official_title>Control of Periodontal Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Forsyth Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GÃ¶teborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Forsyth Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test combined effects of scaling and root planing with
      periodontal surgery, systemically administered amoxicillin and metronidazole, and/or local
      tetracycline on pocket depth reduction and attachment level &quot;gain&quot; in patients with chronic
      periodontitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this 2x2x2 factorial design study, 229 moderate to advanced chronic periodontitis patients
      stratified according to current smoking status were recruited in USA and Sweden. Patients
      were randomly assigned to 8 groups, all of which were treated by SRP plus none, one, two or
      three adjunctive treatments. Thus, patients were assigned to groups that did or did not
      receive Surg, LAb, SAb or LAb+SAb (All) providing 8 treatment combinations (Surg + All, Surg
      + SAb, Surg + LAb, Surg alone, SRP + All, SRP + SAb, SRP + LAb, SRP alone). Clinical,
      microbiological and immunological measurements were taken for 2 years (at baseline, 3, 6, 12,
      18 and 24 months). To focus on changes diseased sites, analysis was restricted to sites with
      baseline pocket depth greater than 5 mm. (also, these were the only sites treated by LAb). In
      this report, main effects and interactions were evaluated for PD reduction and AL gain two
      years post therapy for 187 of patients. Mean values were computed for each treatment group
      and averages after 2 years were compared to baseline by ANOVA. Factorial ANCOVA was used to
      examine significance of differences between Surg or not, SAb or not and LAb or not for PD
      reduction and AL gain using baseline attachment level or pocket depth as covariates and
      including current smoking as a factor.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1999</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Attachment Level Gain</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth reduction</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">187</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Scaling and root planing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>scaling and root planing as a solo therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontal surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>systemic antibiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Local delivery of tetracycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>local antibiotic and systemic antibiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>local antibiotics and surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>systemic antibiotics and surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>local and systemic antibiotics and surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>scaling and root planing</intervention_name>
    <description>scaling and root planing as a single therapy</description>
    <arm_group_label>Scaling and root planing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>local tetracycline</intervention_name>
    <description>local delivery of tetracycline fibers releasing approximately 1.7 mg/tooth in all pockets &gt;5mm</description>
    <arm_group_label>Local delivery of tetracycline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>systemic metronidazole and amoxicillin</intervention_name>
    <description>systemic metronidazole (250 mg tid x 14) and amoxicillin (500 mg bid x 14</description>
    <arm_group_label>systemic antibiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>periodontal surgery in residual pockets of &gt;4mm</description>
    <arm_group_label>Periodontal surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>local antibiotics and systemic metronidazole and amoxicillin</intervention_name>
    <description>1.7 mg/tooth tetracycline fiber plus metronidazole (250 mg tid x14d)and amoxicillin (500 mg bid x 14d)</description>
    <arm_group_label>local antibiotic and systemic antibiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local tetracycline and periodontal surgery</intervention_name>
    <description>local delivery of tetracycline fibers releasing approximately 1.7 mg/tooth in all pockets &gt;5mm and periodontal surgery in residual pockets of &gt;4mm</description>
    <arm_group_label>local antibiotics and surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>periodontal surgery and systemic metronidazole and amoxicillin</intervention_name>
    <description>surgery in residual pockets &gt;4mm and metronidazole (250mg tidx14d) and amoxicillin (500mg bidx14d)</description>
    <arm_group_label>systemic antibiotics and surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>surgery, local tetracycline, systemic metronidazole and amoxicillin</intervention_name>
    <description>periodontal surgery in residual pockets &gt;4mm, tetracycline ibers releasing approximately 1.7 mg/tooth in pockets &gt;5mm, systemic metronidazlo (250mg tidx14d) and amoxicillin (500 mg bidx14d)</description>
    <arm_group_label>local and systemic antibiotics and surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  greater than 20 years of age

          -  had a least 15 natural teeth

          -  in good general health

          -  at least 4 teeth with pockets &gt; 6 mm

          -  at least 8 teeth with AL &gt; 3 mm at baseline

        Exclusion Criteria:

          -  pregnant or nursing (if female)

          -  having antibiotic or periodontal therapy in the previous three months

          -  systemic conditions that would affect the course of periodontal disease

          -  systemic conditions that required antibiotic coverage

          -  allergic to drugs used in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J Max Goodson, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Forsyth Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne D Haffajee, BDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Forsyth Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Forsyth Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2010</study_first_submitted>
  <study_first_submitted_qc>April 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2010</study_first_posted>
  <last_update_submitted>April 1, 2010</last_update_submitted>
  <last_update_submitted_qc>April 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sigmund Socransky</name_title>
    <organization>The Forsyth Institute</organization>
  </responsible_party>
  <keyword>Amoxicillin</keyword>
  <keyword>antibiotics</keyword>
  <keyword>chronic periodontitis</keyword>
  <keyword>local drug delivery</keyword>
  <keyword>metronidazol</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>subgingival scaling</keyword>
  <keyword>surgery</keyword>
  <keyword>tetracycline</keyword>
  <keyword>moderate to advanced chronic periodontitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Tetracycline</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

